Amryt Pharma Plc ADR (AMYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Sales | 222,543 | 182,607 | 58,124 | 17,095 | 0 |
| Cost of Goods | 106,119 | 119,029 | 38,733 | 6,266 | N/A |
| Gross Profit | 116,424 | 63,578 | 19,391 | 10,829 | N/A |
| Operating Expenses | 155,131 | 110,066 | 70,607 | 29,132 | 0 |
| Operating Income | -38,588 | -46,459 | -50,483 | -18,037 | N/A |
| Other Income | 32,026 | -59,400 | -13,010 | -12,407 | 0 |
| Pre-tax Income | -6,562 | -105,859 | -63,493 | -30,444 | 0 |
| Income Tax | -7,562 | -1,332 | -495 | 43 | N/A |
| Net Income Continuous | 1,000 | -104,527 | -62,998 | -30,487 | N/A |
| Net Income | $1,000 | $-104,527 | $-62,998 | $-30,487 | $N/A |
| EPS Basic Total Ops | 0.00 | -3.30 | -4.15 | -3.35 | N/A |
| EPS Basic Continuous Ops | 0.02 | -3.30 | -4.15 | -3.33 | N/A |
| EPS Diluted Total Ops | 0.00 | -3.30 | -4.15 | -3.35 | N/A |
| EPS Diluted Continuous Ops | 0.02 | -3.30 | -4.15 | -3.33 | N/A |
| EPS Diluted Before Non-Recurring Items | 0.03 | -0.66 | -0.86 | N/A | N/A |
| EBITDA(a) | $16,574 | $25,623 | $-30,729 | $-17,670 | $N/A |